Anti-HDV IgM as a marker of disease activity in hepatitis delta
dc.authorid | 0000-0001-6103-5336 | en_US |
dc.authorid | 0000-0003-2137-7934 | en_US |
dc.contributor.author | Wranke, Anika | |
dc.contributor.author | Heidrich, Benjamin | |
dc.contributor.author | Ernst, Stefanie | |
dc.contributor.author | Serrano, Beatriz Calle | |
dc.contributor.author | Caruntu, Florin Alexandru | |
dc.contributor.author | Curescu, Manuela Gabriela | |
dc.contributor.author | Yalçın, Kendal | |
dc.date.accessioned | 2024-04-05T11:35:29Z | |
dc.date.available | 2024-04-05T11:35:29Z | |
dc.date.issued | 2014 | en_US |
dc.department | Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıklar Ana Bilim Dalı | en_US |
dc.description.abstract | Background: Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-HDV IgM could represent such a marker. Methods: Samples of 120 HDV-infected patients recruited in an international multicenter treatment trial (HIDIT-2) were studied. Anti-HDV IgM testing was performed using ETI-DELTA-IGMK-2-assay (DiaSorin). In addition, fifty cytokines, chemokines and angiogenetic factors were measured using multiplex technology (Bio-Plex System). A second independent cohort of 78 patients was studied for the development of liver-related clinical endpoints (decompensation, HCC, liver transplantation or death; median follow up of 3.0 years, range 0.6–12). Results: Anti-HDV IgM serum levels were negative in 18 (15%), low (OD,0.5) in 76 (63%), and high in 26 (22%) patients of the HIDIT-2 cohort. Anti-HDV IgM were significantly associated with histological inflammatory (p,0.01) and biochemical disease activity (ALT, AST p,0.01). HDV replication was independent from anti-HDV IgM, however, low HBV-DNA levels were observed in groups with higher anti-HDV IgM levels (p,0.01). While high IP-10 (CXCL10) levels were seen in greater groups of anti-HDV IgM levels, various other antiviral cytokines were negatively associated with anti-HDV IgM. Associations between anti-HDV IgM and ALT, AST, HBV-DNA were confirmed in the independent cohort. Clinical endpoints occurred in 26 anti-HDV IgM positive patients (39%) but in only one anti-HDV IgM negative individual (9%; p = 0.05). Conclusions: Serum anti-HDV IgM is a robust, easy-to-apply and relatively cheap marker to determine disease activity in hepatitis delta which has prognostic implications. High anti-HDV IgM levels may indicate an activated interferon system but exhausted antiviral immunity. | en_US |
dc.identifier.citation | Wranke, A., Heidrich, B., Ernst, S., Serrano, B. C., Caruntu, F. A., Curescu, M. G. ve diğerleri. (2014). Anti-HDV IgM as a marker of disease activity in hepatitis delta. Public Library of Science, 9(7), 1-13. | en_US |
dc.identifier.doi | 10.1371/journal.pone.0101002 | |
dc.identifier.endpage | 13 | en_US |
dc.identifier.issn | 1932-6203 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.pmid | 25072849 | |
dc.identifier.scopus | 2-s2.0-84904991642 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1 | en_US |
dc.identifier.uri | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0101002 | |
dc.identifier.uri | https://hdl.handle.net/11468/13855 | |
dc.identifier.volume | 9 | en_US |
dc.identifier.wos | WOS:000341307600005 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Yalçın, Kendal | |
dc.language.iso | en | en_US |
dc.publisher | Public Library of Science | en_US |
dc.relation.ispartof | PLoS ONE | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Anti-HDV | en_US |
dc.subject | Hepatitis delta | en_US |
dc.title | Anti-HDV IgM as a marker of disease activity in hepatitis delta | en_US |
dc.title | Anti-HDV IgM as a marker of disease activity in hepatitis delta | |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- Anti-HDV IgM as a marker of disease activity in hepatitis delta.pdf
- Boyut:
- 463.05 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Makale Dosyası
Lisans paketi
1 - 1 / 1
[ X ]
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: